1.
JAMA
; 262(5): 649-52, Aug. 1989.
Artigo
em En
| Desastres
| ID: des-8081
2.
In. Lave, Lester B., ed. Risk assessment and management. New York, U.S. Plenum Press, 1987. p.93-7.
Monografia
em En
| Desastres
| ID: des-9831
RESUMO
In examining the regulatory problem posed by biotechnology, three areas must be considered: 1. the potential benefits to manking, 2. the generation of profits to industry, and 3. the mitigation of isk presented to human helath and the environment. Predictive and analytical tools must be developed and used by regulators to ensure that the rewards of genetic engineering to both mankind and industry are realized with minimal consequence.(AU)